[1-6-19, l'Américain Earl William] Eby gagnant du 400 m [championnats d'athlétisme de l'armée américaine à Colombes] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 54198

1-6-19, Colombes, lancement du marteau [championnats d'athlétisme de l'armée américaine] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 54197

1-6-19, saut à la perche [championnats de l'armée américaine à Colombes] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 54195

Lettre d'Hector Berlioz à son oncle Félix Marmion, [Paris], 13 avril [1859] (manuscrit autographe)

Lettre autographe signée. - Date restituée d'après le contexte : "je suis en train de monter un grand concert spirituel le samedi saint (23)" , ce qui autorise l'année 1859, où Berlioz dirige "L'Enfance du Christ" à l'Opéra-Comique le 23 avril. - A rapprocher d'une lettre à Camille Pal, où Berlioz s'exprime dans ses termes à peu près identiques (C.G. n° 2364). - Lors du concert à Baden le 29 août 1859, Berlioz dirigea des extraits des "Troyens" et non "Roméo et Juliette"

PARP-1 regulates metastatic melanoma through modulation of vimentin-induced malignant transformation.

PARP inhibition can induce anti-neoplastic effects when used as monotherapy or in combination with chemo- or radiotherapy in various tumor settings; however, the basis for the anti-metastasic activities resulting from PARP inhibition remains unknown. PARP inhibitors may also act as modulators of tumor angiogenesis. Proteomic analysis of endothelial cells revealed that vimentin, an intermediary filament involved in angiogenesis and a specific hallmark of EndoMT (endothelial to mesenchymal transition) transformation, was down-regulated following loss of PARP-1 function in endothelial cells. VE-cadherin, an endothelial marker of vascular normalization, was up-regulated in HUVEC treated with PARP inhibitors or following PARP-1 silencing; vimentin over-expression was sufficient to drive to an EndoMT phenotype. In melanoma cells, PARP inhibition reduced pro-metastatic markers, including vasculogenic mimicry. We also demonstrated that vimentin expression was sufficient to induce increased mesenchymal/pro-metastasic phenotypic changes in melanoma cells, including ILK/GSK3-β-dependent E-cadherin down-regulation, Snail1 activation and increased cell motility and migration. In a murine model of metastatic melanoma, PARP inhibition counteracted the ability of melanoma cells to metastasize to the lung. These results suggest that inhibition of PARP interferes with key metastasis-promoting processes, leading to suppression of invasion and colonization of distal organs by aggressive metastatic cells.

Procès du général Fournier [le 13 août 1919 au 2 boulevard des Invalides à Paris] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 55441

Procès du général Fournier [13 août 1919 à Paris] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 55440

Procès du général Fournier [devant le 2 boulevard des Invalides à Paris, le 13 août 1919] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 55439

13-8-19, la vie chère aux halles [de Paris] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 55435

In vivo enzymatic activity of acetylCoA synthetase in skeletal muscle revealed by 13C turnover from hyperpolarized [1-13C]acetate to [1-13C]acetylcarnitine

BACKGROUND: Acetate metabolism in skeletal muscle is regulated by acetylCoA synthetase (ACS). The main function of ACS is to provide cells with acetylCoA, a key molecule for numerous metabolic pathways including fatty acid and cholesterol synthesis and the Krebs cycle. METHODS: Hyperpolarized [1-(13)C]acetate prepared via dissolution dynamic nuclear polarization was injected intravenously at different concentrations into rats. The (13)C magnetic resonance signals of [1-(13)C]acetate and [1-(13)C]acetylcarnitine were recorded in vivo for 1min. The kinetic rate constants related to the transformation of acetate into acetylcarnitine were deduced from the 3s time resolution measurements using two approaches, either mathematical modeling or relative metabolite ratios. RESULTS: Although separated by two biochemical transformations, a kinetic analysis of the (13)C label flow from [1-(13)C]acetate to [1-(13)C]acetylcarnitine led to a unique determination of the activity of ACS. The in vivo Michaelis constants for ACS were KM=0.35±0.13mM and Vmax=0.199±0.031μmol/g/min. CONCLUSIONS: The conversion rates from hyperpolarized acetate into acetylcarnitine were quantified in vivo and, although separated by two enzymatic reactions, these rates uniquely defined the activity of ACS. The conversion rates associated with ACS were obtained using two analytical approaches, both methods yielding similar results. GENERAL SIGNIFICANCE: This study demonstrates the feasibility of directly measuring ACS activity in vivo and, since the activity of ACS can be affected by various pathological states such as cancer or diabetes, the proposed method could be used to non-invasively probe metabolic signatures of ACS in diseased tissue.

1-11-19, [cimetière américain de] Suresnes, fête des morts : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 56737

Expert study: A bolus calculator improves glycemic control and quality of life of type 1 diabetic patients (T1DM) (preliminary results)

Aims: To evaluate the impact on glycemic control and quality of life of a bolus calculator. Methods: Multicentre randomized prospective crosssectional study. Patients were randomized to control phase (3 months; calculation of prandial insulin according to insulinto-carbohydrate ratio and insulin sensitivity factor using a single strip meter) or intervention phase (3 months; calculation of prandial insulin with a bolus advisor), with a washout period (3 months). Patients wore a continuous glucosensor (7 days) and answered a quality of life questionnaire at the beginning and at the end of each phase. A questionnaire of satisfaction was obtained at the end of both phases. Inclusion criteria: Adults; T1DM> 1 year, HbA1c > 7.5%, basal-bolus therapy with insulin analogs, experience with carbohydrate Results: Data from the first 32 subjects with at least 1 ended phase (27 females, age 38 – 11 years, diabetes duration 16.8 – 7.5 years). Basal characteristics were comparable independently of the starting phase. No differences were found between phases in terms of mean blood glucose, standard deviation (from meter neither from sensor) and satisfaction. Conclusions: The use of a bolus calculator improves glycemic control and quality of life of T1DM subjects.

Long-term effects of varying consumption of ω3 fatty acids in ear, nose and throat cancer patients: assessment 1 year after radiotherapy.

Abstract A prospective 1-year follow-up study in ear, nose, and throat (ENT) cancer patients was carried out one year after radiotherapy to assess the effect of varying consumption of ω3 fatty acid according to whether they consumed more or less than the 50th percentile of ω3 fatty acids. Clinical, analytical, inflammatory (CRP and IL-6), and oxidative variables (TAC, GPx, GST, and SOD) were evaluated. The study comprised 31 patients (87.1% men), with a mean age of 61.3 ± 9.1 years. Hematological variables showed significant differences in the patients with a lower consumption of ω3 fatty acids. A lower mortality and longer survival were found in the group with ω3 fatty acid consumption ≥50th percentile but the differences were not significant. No significant difference was reached in toxicity, inflammation, and oxidative stress markers. The group with ω3 fatty acid consumption <50th percentile significantly experienced more hematological and immune changes.

1-11-19, [cimetière de] Bagneux, Toussaint [M. Poincaré et M. Raux, préfet de police] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 56739

1-11-19, [cimetière américain de] Suresnes, fête des morts : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 56738